Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Improved Treatment for Cognitive Impairment in Depression

NCT04317001 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04317001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Improved Treatment for Cognitive Impairment in Depression
Lead sponsor
Stanford University
Phase
Phase 3
Overall status
Withdrawn
Start date
December 1, 2018
Completion date
November 30, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.